| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2017 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | |||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1992 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2015 | 2019 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
interleukin 22 | 0.393 | 0.885 | 1.9E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
heat shock protein family A (Hsp70) member 4 | 0.394 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2015 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 |